Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. - Wikidata - awgldk - TriplyDB

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

http://www.wikidata.org/entity/Q45152760

about

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment The role of systemic treatment before, during, and after definitive treatment Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.Systemic therapy strategies for head-neck carcinomas: Current status Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.Diffusion-weighted imaging in head and neck cancers.Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis.Update on role of chemotherapy in head and neck squamous cell cancer.Pharmacotherapy of head and neck cancer.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study.National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone.Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas.p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer.Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.Strategies for non-resectable head and neck cancer.Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer.A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma.Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.

P2860

Q24235245-8B5491AC-3E58-4301-89FA-A97A720A33AA Q24242951-0065814B-6A0F-4590-8BF5-026BE6127A63 Q26859285-DD956647-CEF8-4C7A-96EC-E65F720F96AA Q33380006-AD496A95-9A29-4257-9305-822534118FCD Q33483238-2E929EC9-45C1-452C-AA49-C3C807D7BE76 Q33491298-5AF8B6DD-F5BE-4132-A3CB-F6415C644F18 Q34369298-FFBBE271-889E-4F3F-BDE8-ED56444EEC5E Q34498577-120A1942-ED3F-4824-8A2F-9048E8441638 Q36022400-A1FE8A9D-CE2D-4F41-BC08-3A85ECE4D61A Q36529843-DB955A9C-46D7-474F-AEA9-74167151C326 Q36613979-9674A3AE-49DF-48AF-9F2A-59F41A304A8D Q36697794-AC99F17D-661C-4205-BB8F-E88D151157D0 Q37093034-8728C2BA-C516-4B30-B541-AADF7A1279AD Q37170947-997569B9-95A7-4E80-92FC-65B0DC1CC9E8 Q37206229-E8E14662-A3A1-42F2-AB8E-0EEED8081344 Q37469917-250EF526-20E3-428E-B4A2-A97BABFC71A7 Q37799933-07A7E28F-666E-4D85-A4A2-6F8D0EFB37F8 Q37930854-C53B6952-DB86-47A9-A680-633772491DE4 Q38038836-37B9BFCC-6C47-42D7-BE69-C2583F564FBA Q38619293-F9C3399A-C6E1-49B8-AF00-9DCEA84D9B79 Q38830809-08949E07-A205-401B-BCDF-24008BCD1EE0 Q39193669-82F53F05-3244-42E4-8AA8-2333270761FB Q39370399-22BB5CBA-AE8E-47DC-9B96-1DCEADA19CC7 Q40060938-15FA3756-B6EB-43B2-946E-1E8156847E9D Q40310924-2519E126-0CD6-4313-9C26-19A75417FC04 Q40421238-32406193-FC21-4F13-92A2-F7BFA040274D Q41382440-AD0C8796-045E-46D5-9289-59DE4DFFD0A1 Q43209150-E859F632-F953-4D76-89E2-610C0887E42D Q43978706-BB1E0C54-45F6-4954-9B31-D17275658A44 Q44536370-F3DE4B24-BE4C-4EE0-94DC-DB997CEBAF26 Q44783059-409EEC78-8428-4B1A-923C-E13A5CB6E55A Q44792291-BEA14079-6D55-4185-BBFE-EF94A3113B76 Q44808667-A1B58BE5-E947-4A68-A98E-272C08E0B560 Q45221883-053CA483-8AA6-4FCD-B45B-ACC6FEBAB078 Q47926809-DA90CE18-BB67-4BF9-B136-4D88E82BC8C7 Q50088438-D99D1714-B800-4A5E-8ECC-A12EB7C6089C Q51740619-52D34D3A-F6CF-4F7F-97B6-3D11D99B64F4 Q52884293-4F808B43-BE9B-4EB6-AB50-EF0B24AFF914

P2860

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

http://www.wikidata.org/entity/Q45152760

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@en

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@nl

type

label

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@en

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@nl

prefLabel

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@en

Randomized phase III trial of ...... eck cancer: 10-year follow-up.

@nl

P1433

Q45152760-68ED32A3-A87F-45A8-84D1-4F681530EDE8

P1476

Q45152760-602ADC9B-EF4B-4BE5-9B19-8A3C9E34D7F8

P2093

Q45152760-05509949-4D1F-43A3-9F2A-D5070A06E235

Q45152760-4373F739-A44B-46DD-B94C-9454B83DE937

Q45152760-4E2F974C-DD63-4BE3-BE29-A940410B1DC1

Q45152760-5AD2FC10-A761-42B8-8DC0-789A84993634

Q45152760-6766F806-4FA7-4B7A-883C-881B055CC8E9

Q45152760-7C2208A2-343F-4C13-BF7E-326580EA154E

Q45152760-9535A95A-3A6E-45DD-B7C4-ADE04DDE32D0

Q45152760-A5D94807-8D92-4C02-BE42-DF9F32F211C9

Q45152760-AC57FA89-D341-41D8-AB7E-DDA3516ED023

Q45152760-C567C7C8-0894-4E3D-9A60-F79D91B338C4

P304

Q45152760-3E6776E5-8B91-4369-B2CB-26D068C8D3D6

P31

Q45152760-75C47852-E5B1-40F1-B7D7-53283AD76673

P356

Q45152760-23B84895-442F-4FFE-9E04-F8A6508D7245

P407

Q45152760-93E0E501-C146-4058-8779-62AB1C19CF5B

P433

Q45152760-128F66F9-5A37-41F6-B143-2EEDE58C88A6

P478

Q45152760-4D351FA0-6585-4DFA-8805-5B3DA59E2B26

P50

Q45152760-4DBE6FD4-DFD8-4DA3-AC9E-672F1E38B6C7

P577

Q45152760-8C20B3D5-BE96-457A-9CBE-E70424A1463C

P5875

Q45152760-573F084F-F8BF-4974-AB2A-DA7B98D6046E

P698

Q45152760-3767438A-033C-4711-954C-E9D1E75D891B

P921

Q45152760-3291E0A7-4C8E-4797-A835-2FF71FB92D9A

Q45152760-7F1AB002-1C5F-4FE9-A934-904E845B43EB

P356

P1433

Journal of the National Cancer Institute

P1476

Randomized phase III trial of ...... neck cancer: 10-year follow-up

@en

P2093

Adriano Paccagnella

http://www.w3.org/2001/XMLSchema#string

Alessandro Bordin

http://www.w3.org/2001/XMLSchema#string

Alessandro Gava

http://www.w3.org/2001/XMLSchema#string

Antonella Fede

http://www.w3.org/2001/XMLSchema#string

Antonio Jirillo

http://www.w3.org/2001/XMLSchema#string

Antonio Orlando

http://www.w3.org/2001/XMLSchema#string

Carlo Alberto Mione

http://www.w3.org/2001/XMLSchema#string

Carlo Marchiori

http://www.w3.org/2001/XMLSchema#string

Fanny Boldrin

http://www.w3.org/2001/XMLSchema#string

Francesco Lunghi

http://www.w3.org/2001/XMLSchema#string

P304

1714-1717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJH306

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Maria Cristina Da Mosto

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8180322

http://www.w3.org/2001/XMLSchema#string

P698

15547184

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial